Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
87.99
+0.88 (+1.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
18
19
Next >
Albertsons Companies, Domino's Pizza And Other Big Gainers From Thursday
October 14, 2022
U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
COLA 2023: How Much Did Social Security Benefits Increase for 2023?
October 13, 2022
Social Security is increasing for 2023 as the Social Security Administration announces an update to the Cost-of-Living Adjustment (COLA).
Via
InvestorPlace
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
October 13, 2022
Sometimes, company shares can catch a bid when a rival gets bad news. That's happening with Axsome today as AXSM stock moves higher.
Via
InvestorPlace
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
October 13, 2022
The company noted "paradoxical results" where the placebo, at times, topped the drug.
Via
Investor's Business Daily
Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket
October 13, 2022
Gainers Laser Photonics Corporation (NASDAQ: LASE) shares rose 45% to $4.24 in pre-market trading. Laser Photonics announced that Coca-Cola recently completed the implementation of its first CleanTech...
Via
Benzinga
Better Buy: Moderna vs. Axsome Therapeutics
October 10, 2022
Both of these biotechs offer exciting future prospects.
Via
The Motley Fool
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 13, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday.
Via
Benzinga
Delta Air Lines, Walgreens Boots Alliance And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 13, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
Investors are betting on these companies' revenue growth prospects.
Via
The Motley Fool
Axsome Therapeutics' Sunosi Improves Cognitive Function In Patients With Sleep Disorder
October 03, 2022
Via
Benzinga
8 Analysts Have This to Say About Axsome Therapeutics
September 30, 2022
Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:
Via
Benzinga
Mizuho Bolsters Price Target By 55% On This Migraine Stock
September 07, 2022
Via
Benzinga
Got $1,000? These 3 Stocks Could Double Your Money in 5 Years.
October 12, 2022
All three stocks are worth keeping a lot longer than half a decade.
Via
The Motley Fool
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold
October 12, 2022
Vertex already generates billions in revenue -- but there may be more to come.
Via
The Motley Fool
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
October 10, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
This article looks at seven biotech stocks that look like good options to move significantly higher in 2023
Via
InvestorPlace
If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today
October 08, 2022
Could the stock keep performing?
Via
The Motley Fool
Analyst Ratings for Axsome Therapeutics
August 30, 2022
Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings:
Via
Benzinga
Jim Cramer On This Industrial Stock: 'You Don't Know What's In It'
October 07, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Sociedad Quimica y Minera de Chile (NYSE: SQM) as "fertilizer’s in short supply and so is lithium."
Via
Benzinga
3 Stocks Savvy Investors Are Buying Hand Over Fist
October 06, 2022
These high-flying stocks are defying the bear market.
Via
The Motley Fool
Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint Demonstrating Improvement in Cognitive Function in the SHARP Trial in Cognitively Impaired Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea
October 03, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
September 29, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022
September 20, 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.
Via
Talk Markets
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
Via
InvestorPlace
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
September 12, 2022
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.
Via
InvestorPlace
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
Via
Benzinga
Axsome Therapeutics Commences Late-Stage Migraine Study
September 01, 2022
Axsome Therapeutics (NASDAQ: AXSM) has enrolled the first patient in the EMERGE trial of its lead candidate AXS-07 for the acute treatment of migraine.
Via
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.